Lindbrook Capital’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $4.89K | Sell |
326
-747
| -70% | -$11.2K | ﹤0.01% | 1962 |
|
|
2024
Q4 | $18.6K | Buy |
1,073
+40
| +4% | +$692 | ﹤0.01% | 1321 |
|
|
2024
Q3 | $19.1K | Sell |
1,033
-741
| -42% | -$13.7K | ﹤0.01% | 1324 |
|
|
2024
Q2 | $36K | Sell |
1,774
-1,939
| -52% | -$39.3K | ﹤0.01% | 933 |
|
|
2024
Q1 | $63.4K | Buy |
3,713
+612
| +20% | +$10.5K | 0.01% | 688 |
|
|
2023
Q4 | $54.8K | Sell |
3,101
-79
| -2% | -$1.4K | 0.01% | 719 |
|
|
2023
Q3 | $76.4K | Buy |
3,180
+58
| +2% | +$1.39K | 0.01% | 541 |
|
|
2023
Q2 | $72.6K | Hold |
3,122
| – | – | 0.01% | 583 |
|
|
2023
Q1 | $68.8K | Buy |
3,122
+66
| +2% | +$1.46K | 0.01% | 586 |
|
|
2022
Q4 | $61.9K | Buy |
3,056
+256
| +9% | +$5.19K | 0.01% | 614 |
|
|
2022
Q3 | $38K | Buy |
2,800
+51
| +2% | +$692 | 0.01% | 748 |
|
|
2022
Q2 | $54K | Buy |
2,749
+11
| +0.4% | +$216 | 0.01% | 625 |
|
|
2022
Q1 | $87K | Hold |
2,738
| – | – | 0.01% | 501 |
|
|
2021
Q4 | $61K | Hold |
2,738
| – | – | 0.01% | 652 |
|
|
2021
Q3 | $76K | Hold |
2,738
| – | – | 0.02% | 328 |
|
|
2021
Q2 | $107K | Hold |
2,738
| – | – | 0.02% | 279 |
|
|
2021
Q1 | $79K | Hold |
2,738
| – | – | 0.02% | 316 |
|
|
2020
Q4 | $73K | Hold |
2,738
| – | – | 0.02% | 304 |
|
|
2020
Q3 | $42K | Hold |
2,738
| – | – | 0.01% | 397 |
|
|
2020
Q2 | $56K | Buy |
2,738
+2,393
| +694% | +$48.9K | 0.02% | 337 |
|
|
2020
Q1 | $4K | Buy |
345
+303
| +721% | +$3.51K | ﹤0.01% | 1066 |
|
|
2019
Q4 | $2K | Buy |
+42
| New | +$2K | ﹤0.01% | 1272 |
|